Hepatitis C Virus Infection Completed Phase 2 Trials for Ledipasvir (DB09027)

Back to Hepatitis C Virus Infection

Indication	Status	Phase
DBCOND0033268 (Hepatitis C Virus Infection)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03036839	Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02868242	Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02413593	Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection	Treatment	Ledipasvir (DB09027) Ribavirin (DB00811) Sofosbuvir (DB08934)
NCT02350569	Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02301936	Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02251717	Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)
NCT02249182	Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection	Treatment	Ledipasvir (DB09027) Ribavirin (DB00811) Sofosbuvir (DB08934)
NCT02226549	Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis	Treatment	Ledipasvir (DB09027) Ribavirin (DB00811) Sofosbuvir (DB08934) Vedroprevir (DB12037)
NCT02219685	Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection	Treatment	Ledipasvir (DB09027) Sofosbuvir (DB08934)